Public procurement notices · 1 filter

ACHIZITIE MEDICAMENTE PROGRAMUL NATIONAL DE ONCOLOGIE

cn1079654 · SEAP/SICAP · Contract notice

S.C. GRAL MEDICAL S.R.L. · Romania

Evaluating offers

RON 243,632,400⏰ 05 May 202502 Apr 2025

ACHIZITIE MEDICAMENTE PROGRAMUL NATIONAL DE ONCOLOGIE

cn1009096 · SEAP/SICAP · Contract notice

S.C. GRAL MEDICAL S.R.L. · Romania

Evaluating offers

RON 41,127,082⏰ 18 Mar 201918 Feb 2019

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41568366 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 55,92005 Nov 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41554780 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 79,88504 Nov 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41431083 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 51,92519 Oct 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41418899 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 39,94315 Oct 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41418657 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 15,97715 Oct 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41293878 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 7,98929 Sept 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41173968 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 79,88514 Sept 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da41003595 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 23,96617 Aug 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40968552 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 11,98310 Aug 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40796071 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 119,82809 Jul 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40594346 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 11,98310 Jun 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40353594 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 47,93111 May 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40165700 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 7,98909 Apr 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da40162624 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 15,97708 Apr 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da39940582 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 82,31304 Mar 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da39817545 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 11,75911 Feb 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da39783135 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 78,394⏰ 05 Feb 202605 Feb 2026

Caelyx pegylated liposomal 2mg/ml sol.perf. 10ml x 1 fl. BBD 2/28/2026

da39774129 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Cancelled

RON 2,56704 Feb 2026

ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml

da38890835 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 23,518⏰ 17 Sept 202517 Sept 2025

Doxorubicina 2mg/ml-conc.pt.sol.perf. x 25ml x 1fl-Accord Healthcare PL DOXORUBICINUM

da38361320 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Unknown

RON 3,701⏰ 23 Jun 202518 Jun 2025

Doxorubicina 2mg/ml-conc.pt.sol.perf. x 25ml x 1fl-Accord Healthcare PL DOXORUBICINUM

da38359573 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Unknown

RON 243⏰ 23 Jun 202518 Jun 2025

Cisplatina Accord 1 mg / ml x 1 flac. x 50 ml conc. pt. sol. perf. / CISPLATINUM

da36656732 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Awarded

RON 11,495⏰ 09 Oct 202407 Oct 2024

AVASTIN 25MG/ML CONC PT SOL PERF FL*16 ML / AVASTIN 25MG/ML CONC PT SOL PERF FL*4 ML

da36585328 · SEAP/SICAP · Direct award

S.C. GRAL MEDICAL S.R.L. · Romania

Unknown

RON 8,644⏰ 27 Sept 202425 Sept 2024